{"disease":{"id":"intellectual-deficiency","name":"intellectual deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03287206","title":"Medico-economic Evaluation of Different High-throughput Sequencing Strategies in the Diagnosis of Patients With Intellectual Deficiency","phase":"","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT05518188","title":"Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":4,"lead_sponsor_name":"Elpida Therapeutics SPC","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}